ethyl 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetate | 70598-01-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetate
• 英文别名: ethyl 2-(1,3,5-trimethylpyrazol-4-yl)acetate
• CAS: 70598-01-5
• 化学式: C₁₀H₁₆N₂O₂
• mdl: MFCD08701199
• 分子量: 196.249
• InChiKey: KPADBJAWODCXTR-UHFFFAOYSA-N

物化性质

• 沸点：
  285.5±35.0 °C(Predicted)
• 密度：
  1.08±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  44.1
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  Sealed in a dry room at room temperature.

反应信息

• 作为反应物：
  描述：

  ethyl 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetate 在 1,2,2,6,6-五甲基哌啶 、 lithium hydroxide monohydrate 、 间甲苯磺酰氯 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 54.0h， 生成 2-(3-(piperidin-4-yloxy)benzo[b]thiophen-2-yl)-5-((1,3,5-trimethyl-1H-pyrazol-4-yl)methyl)-1,3,4-oxadiazole
  参考文献：
  名称：

  Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)

  摘要：

  N-Myristoyltransferase (NMT) is an essential eukaryotic enzyme and an attractive drug target in parasitic infections such as malaria. We have previously reported that 2-(3-(piperidin-4-yloxy)benzo[b]thiophen-2-yl)-5-((1,3,5-trimethyl-1H-pyrazol-4-yl)methyl)-1,3,4-oxadiazole (34c) is a high affinity inhibitor of both Plasmodium falciparum and P. vivax NMT and displays activity in vivo against a rodent malaria model. Here we describe the discovery of 34c through optimization of a previously described series. Development, guided by targeting a ligand efficiency dependent lipophilicity (LELP) score of less than 10, yielded a 100-fold increase in enzyme affinity and a 100-fold drop in lipophilicity with the addition of only two heavy atoms. 34c was found to be equipotent on chloroquine-sensitive and -resistant cell lines and on both blood and liver stage forms of the parasite. These data further validate NMT as an exciting drug target in malaria and support 34c as an attractive tool for further optimization.

  DOI：

  10.1021/jm500066b
• 作为产物：
  描述：

  乙酰丙酮 在 sodium hydride 、 溶剂黄146 作用下， 以 四氢呋喃 为溶剂， 反应 22.0h， 生成 ethyl 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetate
  参考文献：
  名称：

  [EN] NOVEL COMPOUNDS AND THEIR USE IN THERAPY
  [FR] NOUVEAUX COMPOSÉS ET LEUR UTILISATION EN THÉRAPIE

  摘要：

  这项发明提供了抑制N-肉豆蔻酰基转移酶并且对原生动物N-肉豆蔻酰基转移酶具有选择性的化合物，因此适用于治疗微生物感染，包括病毒和真菌感染，以及疟疾、利什曼病和睡眠病等原生动物感染。

  公开号：

  WO2013083991A1

文献信息

• [EN] COMPOUNDS AND THEIR USE AS INHIBITORS OF N-MYRISTOYL TRANSFERASE<br/>[FR] COMPOSÉS ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA N-MYRISTOYL TRANSFÉRASE
  申请人：IMP INNOVATIONS LTD

  公开号：WO2017001812A1

  公开（公告）日：2017-01-05

  This invention provides compounds of formula (I) and salts thereof, which have activity as inhibitors of N-myristoyl transferase (NMT). The invention also relates to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of N-myristoyl transferase provides a therapeutic or prophylactic effect, including protozoan infections (such as malaria and leishmaniasis), viral infections (such as human rhinovirus and HIV), and hyperproliferative disorders (such as B-cell lymphoma).

  这项发明提供了式（I）的化合物及其盐，具有作为N-肉豆蔻酰转移酶（NMT）抑制剂的活性。该发明还涉及将这类化合物用作药物的用途，特别是在治疗需要抑制N-肉豆蔻酰转移酶以产生治疗或预防效果的疾病或紊乱中，包括原虫感染（如疟疾和利什曼病）、病毒感染（如人类鼻病毒和HIV）以及高增殖性疾病（如B细胞淋巴瘤）。
• 2-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-3-PHENYL PYRAZINES AND PYRIDINES AND 3-[4-(PYRAZOL-4-YLALKYL)PIPERAZIN-1-YL]-2-PHENYL PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS
  申请人：Badescu Valentina O.

  公开号：US20100120785A1

  公开（公告）日：2010-05-13

  The present invention provides selective 5-HT 7 receptor antagonist compounds of Formula I and their use in the treatment of migraine, persistent pain, and anxiety: where A and B are each independently C(H)═ or N═, provided that at least one of A and B is —N═, n is 1-3, m is 0-3, and R 14 are as defined herein.

  本发明提供了5-HT7受体拮抗剂化合物I的选择性，并且这些化合物可用于治疗偏头痛、持续性疼痛和焦虑症。其中，A和B各自独立地为C(H)═或N═，但至少有一个A和B是—N═，n为1-3，m为0-3，R14如本文所定义。
• 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists
  申请人：Eli Lilly and Company

  公开号：US08202873B2

  公开（公告）日：2012-06-19

  The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine, persistent pain, and anxiety: where A and B are each independently —C(H)═ or —N═, provided that at least one of A and B is —N═, n is 1-3, m is 0-3, and R1-4 are as defined herein.

  本发明提供了式I的选择性5-HT7受体拮抗剂化合物及其在治疗偏头痛、持续性疼痛和焦虑症方面的用途：其中A和B分别独立地为—C(H)═或—N═，但至少其中之一为—N═，n为1-3，m为0-3，R1-4如本文所定义。
• Compounds and their use as inhibitors of N-myristoyl transferase
  申请人：Imperial College Innovations Limited

  公开号：US10759804B2

  公开（公告）日：2020-09-01

  This invention provides compounds of formula (I) and salts thereof, which have activity as inhibitors of N-myristoyl transferase (NMT). The invention also relates to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of N-myristoyl transferase provides a therapeutic or prophylactic effect, including protozoan infections (such as malaria and leishmaniasis), viral infections (such as human rhinovirus and HIV), and hyperproliferative disorders (such as B-cell lymphoma).

  本发明提供了式(I)化合物及其盐类，它们具有作为N-肉豆蔻酰转移酶(NMT)抑制剂的活性。本发明还涉及此类化合物作为药物的用途，特别是在治疗抑制 N-肉豆蔻酰基转移酶可提供治疗或预防效果的疾病或紊乱中的用途，包括原生动物感染（如疟疾和利什曼病）、病毒感染（如人类鼻病毒和 HIV）和过度增殖性紊乱（如 B 细胞淋巴瘤）。
• WO2008/141020
  申请人：——

  公开号：——

  公开（公告）日：——